Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for first toe spasticity in neurological patients
2020-005653-24Phase 4Active
- Sponsor
- Clínica Integral del pie-Ana Sans
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A in Muscle spasm, bunion deformity (HAV) and spasticity (2 arms), sponsored by Clínica Integral del pie-Ana Sans. Primary endpoint: Efficacy of botulinum toxin infiltration for first toe spasticity. Started Jun 2021; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasmbunion deformity (HAV)spasticity
Beyond the preview
Go deeper on 2020-005653-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005653-24.